Dr. Lawrence Tabak, Principal Deputy Director, NIH

The National Institutes of Health Clinical Center has suspended operation of its Pharmaceutical Development Section in Bethesda. The move follows an inspection ...

The National Institutes of Health Clinical Center has suspended operation of its Pharmaceutical Development Section in Bethesda. The move follows an inspection by the Food and Drug Administration that was prompted by a whistleblower. Inspectors found a series of operating and handling deficiencies, including experimental drugs contaminated with fungus. Dr. Lawrence Tabak joined Tom Temin on the Federal Drive with more on what NIH found and what it’s doing to fix the problem.

Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.

    Joint Chiefs Chairman

    Though the Defense Department managed to go unscathed through the Crowdstrike outage, it remains on the alert

    Read more
    USPS, EV, USPS electric vehicles

    The road to electrifying America’s personal vehicles starts with the USPS EV fleet

    Read more
    Congress, budget, budget cut, spending cuts, Capitol, Congress, federal budget

    Congress tackles spending, policy and candidate protections on the road to the August recess

    Read more